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AbsTrACT
Objective Research in European Paediatric Emergency 
Medicine (REPEM) network is a collaborative group of 69 
paediatric emergency medicine (PEM) physicians from 20 
countries in Europe, initiated in 2006. To further improve 
paediatric emergency care in Europe, the aim of this 
study was to define research priorities for PEM in Europe 
to guide the development of future research projects.
Design and setting We carried out an online survey in 
a modified three-stage Delphi study. Eligible participants 
were members of the REPEM network. In stage 1, the 
REPEM steering committee prepared a list of research 
topics. In stage 2, REPEM members rated on a 6-point 
scale research topics and they could add research topics 
and comment on the list for further refinement. Stage 3 
included further prioritisation using the Hanlon Process 
of Prioritisation (HPP) to give more emphasis to the 
feasibility of a research topic.
results Based on 52 respondents (response rates per 
stage varying from 41% to 57%), we identified the 
conditions ’fever’, ’sepsis’ and ’respiratory infections’, 
and the processes/interventions ’biomarkers’, ’risk 
stratification’ and ’practice variation’ as common themes 
of research interest. The HPP identified highest priority 
for 4 of the 5 highest prioritised items by the Delphi 
process, incorporating prevalence and severity of each 
condition and feasibility of undertaking such research.
Conclusions While the high diversity in emergency 
department (ED) populations, cultures, healthcare 
systems and healthcare delivery in European PEM 
prompts to focus on practice variation of ED conditions, 
our defined research priority list will help guide further 
collaborative research efforts within the REPEM network 
to improve PEM care in Europe.
InTrODuCTIOn
Paediatric emergency medicine (PEM) has been a 
well-recognised subspecialty for decades in Canada, 
the USA and Australia.1–3 PEM physicians own a 
unique skillset to provide optimal appropriate and 
efficient care to acutely ill and injured children in 
the dynamic, multitasking and often overcrowded 
environment of the emergency department (ED). 
In this setting, the few children with serious condi-
tions blend within the great majority of patients 
presenting with self-limiting illnesses. Despite the 
lack of official recognition of its own identity and 
formal training requirements in most European 
countries, except for the UK, Switzerland, Turkey 
and Israel, PEM has been practised in many coun-
tries in Europe, leading to heterogeneous quality of 
care of children presenting to European paediatric 
or mixed EDs.4 5 
Following worldwide initiatives,2 3 6 7 the 
Research in European Paediatric Emergency Medi-
cine (REPEM) network was founded in 2006 
to improve emergency care for children in 
Europe,4 8 9 consisting of 69 partners from 20 Euro-
pean countries. The UK and Ireland have founded 
their own research network6 but collaborate with 
REPEM in some research projects. Compared 
with existing (multi)national networks of English-
speaking countries, REPEM is faced with unique 
challenges related to its high diversity in ED popu-
lations, cultures and diversity in delivered health 
and healthcare systems. Similar to other research 
networks,2 3 7 10 11 we need to establish our research 
agenda relevant to PEM in Europe to guide the 
development of future research projects, which 
should not be exclusively based on members’ inter-
ests and prior work in a specific research field.
Therefore, the aim of this study was to define 
research priorities in the area of PEM for a collabo-
rative network in Europe.
What is already known on this topic?
 ► Paediatric emergency medicine (PEM) has been 
a well-recognised subspecialty for decades in 
Canada, the USA and Australia.
 ► Research in European Paediatric Emergency 
Medicine (REPEM) network is faced with 
unique challenges related to its high diversity of 
countries, languages and healthcare systems.
What this study adds?
 ► REPEM members identified common research 
priorities on the following themes: ‘fever’, 
‘sepsis’, ‘respiratory infections’, ‘biomarkers’, 
‘risk stratification’ and ‘practice variation’.
 ► The high diversity in ED populations, cultures, 
healthcare systems and healthcare delivery in 
European PEM prompts to focus on practice 
variation of ED conditions.
 ► Large multicentre collaborations such as 
REPEM are nowadays essential to include 
large population samples to study rare but 
high-impact conditions, such as sepsis, and risk 
stratification in European PEM.
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MeThODs
study design
We carried out an online survey in a modified three-stage Delphi 
study (figure 1).12 Other research networks have conducted 
similar studies to systematically determine research priorities 
using consensus methodology.2 3 7 10 Eligible participants were 
invited from the REPEM network, consisting of 69 members.
Modified Delphi stage 1 preparation
This stage aimed to define the list of research topics to be ranked 
further by REPEM members in the Delphi process.
The REPEM steering committee (SC, n=11 members) was 
asked to review priority items from previous publications of 
other PEM networks (PERC, PERUKI, PERN, PREDICT)2 3 7 10 
and to add items to this list if considered important from the 
European perspective. To this composed list SC members then 
assigned priorities by scaling items from 1 (low) to 6 (high 
priority). Items ranked 4 or higher by >6 out of 11 SC members 
selected for the final list used in stage 2.
Modified Delphi stage 2
Stage 2 consisted of two online surveys. All REPEM members 
were asked to prioritise each item, on a scale of 1–6. They could 
add comments and suggest additional (missing) topics. Based on 
the survey’s results and respondents’ comments, the list of topics 
was refined and reduced for the second survey. Suggested items 
were added. Items with two-third or more respondents ranking 
them 4 or lower on the priority scale were removed.
Modified Delphi stage 3: hanlon Process of Prioritisation
In a modified Hanlon Process of Prioritisation (HPP),2 13 we 
weighted prevalence and seriousness of the condition and feasi-
bility of conducting research projects on that condition to prior-
itise health condition. An HPP score was calculated for each item 
using the mean scores for each of the three domains (A, B, C) 
as follows: HPP=(A+2B)×C. This process was carried out by a 
third online survey.
Analysis
In each stage, we computed cumulative percentages for the 
priority levels for each item and mean priority scores with SD.
resulTs
Participants’ responses to surveys
All 11 SC members participated in the preparation phase and 
contributed to modified Delphi stage 2 and 3. In total, 52 of the 
69 invitees participated in one of the Delphi stages with response 
rates varying from 41% to 57% (table 1). Participants were all 
PEM specialists, practising in tertiary EDs.
Modified Delphi stage 1 (preparation)
In addition to other PEM-networks research priority exer-
cises, the SC suggested ‘child abuse’, ‘care of refugee children’, 
‘ultrasound’, ‘simulation’, ‘implementation’, ‘patient-reported 
outcomes’ and ‘pathways of ED conditions’ as additional priority 
topics. Items ‘new technologies’, ‘risk stratification’, ‘antibiotic 
stewardship’ and ‘fluid therapy in gastroenteritis’ were rephrased 
Figure 1 Flow chart of the study. HPP, Hanlon Process of Prioritisation; PEM, paediatric emergency medicine; REPEM, Research in European 
Paediatric Emergency Medicine; SC, steering committee. 
Table 1 Number of REPEM respondents per country and per survey 
phase
stage 2 stage 3
Totalsurvey 1 survey 2 survey 3, hPP
Invited REPEM members 69 69 69 69
Austria 1 1 1 1
Belgium 1 1 1
France 4 1 3 4
Germany 1 1 1
Hungary 2 1 2 3
Israel 1 2 1 2
Italy 5 4 2 6
Latvia 1 1 1 1
Lithuania 1 1
Malta 1 1
The Netherlands 3 3 1 3
Portugal 1 1 1
Spain 6 6 5 7
Sweden 2 2
Switzerland 6 3 5 7
Turkey 4 5 3 6
UK 3 2 3 4
All 39 (57%) 35 (51%) 28 (41%) 52 (75%)
HPP, Hanlon prioritisation process; REPEM, Research in European Paediatric Emergency 
Medicine.
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from other PEM-networks prioritised items. Stage 1 ended with 
a list of 35 topics, on areas infectious diseases, the critically ill 
patient, paediatric trauma, neurology, diagnostic procedures, 
therapy and items of organisation of care and quality of care. By 
prioritisation, 19 items were selected by the SC for the further 
Delphi stages (table 2).
Modified Delphi stage 2 (two surveys)
In the first survey, ‘refugee children’ achieved lowest priority 
(3.87); ‘risk stratification’ highest (5.08) (table 2). Items selected 
included ‘fever’, ‘sepsis’, ‘respiratory illness’, ‘biomarkers’, ‘risk 
stratification’, ‘new technologies’. The majority ranked ‘child 
abuse', care of refugee children’, ‘paediatric early warning 
score’, ‘ED organisation’, ‘patient-reported outcomes’ to scores 
4 or lower. Suggestions included ‘malpractice’, ‘health services 
research’, ‘trauma’ (management of major trauma and minor 
head trauma) and ‘poisoning’. The latter two were suggested 
during the preparation phase, but did not achieve sufficient 
priority then. During refinement, processes/interventions were 
specified for specific conditions, for example, ‘biomarkers for 
fever’ and ‘risk stratification in trauma’.
Survey 2 included five conditions, three processes and two 
interventions. Next, we composed combined items for condi-
tions and processes/interventions, and open questions to suggest 
new technologies for these conditions. ‘Biomarkers in trauma’ 
achieved lowest priority scores (3.91); ‘risk stratification in 
sepsis’ highest (5.11) (table 3). Although suggested in survey 1, 
‘poisoning’ did not achieve sufficient priority and was together 
with ‘security’ and ‘access to healthcare’ removed for the next 
prioritisation round.
Suggested new topics during the second survey included 
‘standardised pathways of care’, ‘external validations for clin-
ical outcomes’, ‘focus on young infants’, ‘e-health’ and ‘rapid 
tests for fever’. For trauma, suggested new technologies included 
‘devices/guidance for intubation in the ED’, ‘CT, MRI and ultra-
sound in the ED’; other suggested items were use of ‘tranexamic 
acid’ and ‘prognosis’.
Modified Delphi stage 3 (hPP)
The HPP identified highest priority for four of the five highest 
prioritised items by the Delphi (table 4). Feasibility concerns for 
‘fever’ included the diversity of conditions covered by the broad 
term ‘fever’, and some members questioned its importance 
given the high amount of data available in literature. For ‘sepsis’ 
members commented on the need for definitions, and the low 
feasibility to detect unfavourable outcomes. Research in ‘respi-
ratory infections’ was considered important given the high prev-
alence, but subject to the absence of a clear definition of ‘type 
and origin’. ‘Trauma’ was reported to be an under-researched 
area compared with other ED conditions, but hampered by low 
frequency of major trauma, and high diversity of trauma types. 
In addition, not all paediatric ED centres in Europe manage 
trauma.
DIsCussIOn
In a modified three-stage Delphi among REPEM members, we 
identified common themes of research interest: ‘fever’, ‘sepsis’ 
and ‘respiratory infections’, ‘biomarkers’, ‘risk stratification’ and 
‘practice variation’. Although not to be used as limitation, this 
list will help guide further collaborative research supported by 
our research network.
Incorporating prevalence, severity and feasibility of under-
taking such research by using the HPP selected four of the top 
five prioritised items. The high priority to study practice varia-
tion of ED conditions may arise from the multinational, multi-
cultural, multilanguage European landscape, with different 
healthcare systems and organisations. Correctly interpret vari-
ation in paediatric emergency care may elicit causative relations 
and contribute to inspiration for areas of improvement. Studying 
rare high-impact conditions as sepsis, and risk stratification for 
common conditions require large population samples to conduct 
adequately powered studies on low frequency-high stakes condi-
tions and to ensure representativeness of European diversity 
in geography and culture for generalisable results. A critical 
Table 2 Priority ranking Delphi stage 2, survey 1 (n=39 respondents)
Type Topic Mean priority (sD)
lowest priority 
assigned
highest priority 
assigned
% prioritising 5 or 
higher
C Sepsis 4.97 (1.04) 2 6 69.2
C Fever 4.95 (1.15) 2 6 69.2
C Respiratory illness 4.87 (1.06) 2 6 71.8
C Paediatric cardiopulmonary arrest 4.67 (1.36) 2 6 56.4
C Child abuse 4.36 (1.04) 2 6 46.2
C Care for refugee children 3.87 (1.32) 1 6 35.9
I Risk stratification 5.08 (0.98) 2 6 74.4
I Biomarkers 5.05 (0.83) 3 6 79.5
I New PED technologies 5.05 (0.97) 3 6 76.9
P Knowledge translation/implementation 4.69 (1.03) 2 6 61.5
P Antibiotic stewardship 4.69 (1.26) 1 6 59.0
P Pathways of PED conditions 4.59 (1.04) 2 6 61.5
I Triage 4.59 (1.19) 2 6 61.5
I Ultrasonography 4.54 (1.17) 1 6 61.5
P Simulation 4.54 (1.32) 2 6 51.3
I Procedural sedation and analgesia 4.51 (1.21) 1 6 59.0
P PED organisation 4.44 (1.21) 2 6 46.2
P Patient-reported outcomes 4.33 (1.24) 1 6 41.0
I PEWS 4.23 (1.20) 2 6 46.2
C, condition, I, intervention; P, process; PED, paediatric emergency department; PEWS, paediatric early warning score.
Protected by copyright.
 o
n
 D
ecem
ber 11, 2019 at Erasm
us M
edical / X51 4300.7802.430.
http://adc.bmj.com/
Arch D
is Child: first published as 10.1136/archdischild-2019-316918 on 25 April 2019. Downloaded from
 
4 Bressan S, et al. Arch Dis Child 2019;0:1–5. doi:10.1136/archdischild-2019-316918
Original article
mass can only be provided by large multicentre collaborations 
including a wide set of participant countries.9
Not all topics achieved sufficient high priority, due to larger 
respondents’ variability in prioritisations. Respondents may have 
prioritised differently based on availability, and feasibility for 
implementation in the respondents’ ED working environment. 
The priority ranking of ‘trauma’ was influenced by the diversity 
of the types of trauma and low prevalence of major trauma. So 
this research area needs to be better defined. ‘Poisoning’ has been 
studied already by REPEM members within the PERN collabora-
tion.4 5 Topics ‘ultrasonography’, ‘triage’ and ‘procedural seda-
tion’ with frequent scores of 5–6 (>60%) seem to be promising 
areas for successful collaborative research as well. Other topics, 
such as ‘implementation of knowledge’, ‘pathways of managing 
ED conditions’ and ‘in-house simulation’ reflect the need to effi-
ciently implement knowledge into clinical ED practice. Dissem-
ination and implementation of evidence-based guidelines for 
emergent conditions, customised to local practice is important,11 
in particular considering the large number of children presenting 
to European EDs annually and the heterogeneous status of PEM 
in Europe. This will ensure provision of up-to-date optimal care, 
reduce variation in practice, improve patient outcome and expe-
rience of care as well as optimise resource utilisation.
Our results may deviate from other network priority exer-
cises2 3 7 10 due to the survey itself or the intrinsic characteris-
tics of REPEM. We did not define specific research questions, 
but merely identified research areas. Next, in contrast to other 
networks, REPEM members are all affiliated to tertiary paedi-
atric emergency care settings with high research priority and 
do not cover the whole European area. This may have influ-
enced the selected items, although our priority list includes the 
most common reasons for ED attendance in childhood, such as 
fever and respiratory infections, with dilemmas on risk stratifi-
cation and diagnostic testing. Response rates were quite similar 
to surveys from other networks with participation of 75% of 
hospitals and 85% of countries involved in the REPEM network. 
Therefore, we think our results reflect the European research 
perspective in PEM. Other existing networks comprise English-
speaking countries; the REPEM network consists of a high 
diversity of European countries, with their specific political, 
historical, cultural and socioeconomic traditions in the medical 
field, guidelines and healthcare systems. For example, Europe 
has a variable a priori risk of serious infections due to different 
vaccination strategies among countries. In addition, healthcare 
providers for emergent paediatric trauma range from commu-
nity paediatricians (11% of countries) to paediatric surgeons 
Table 3 Priority ranking Delphi stage 2, survey 2 (n=35 respondents)
Type Item Mean priority (sD)
lowest priority 
assigned
highest priority 
assigned
% prioritising 5 or 
higher
Items new suggested in/adapted after Delphi stage 1
C Trauma 4.60 (1.29) 1 6 57.1
C Poisoning 4.06 (1.06) 2 6 34.3
P Health services research 3.89 (0.96) 2 6 22.9
P Safety/security 4.14 (1.33) 1 6 42.9
P Practice variation 4.51 (1.14) 2 6 60.0
I Risk stratification 4.54 (1.17) 2 6 60.0
Combination of conditions and process/intervention
P Practice variation
  in sepsis 5.03 (0.92) 3 6 71.4
  in fever 4.66 (1.08) 2 6 57.1
  in RTI 4.60 (0.91) 2 6 51.4
  in trauma 4.37 (1.00) 2 6 42.9
I Risk stratification
  in sepsis 5.11 (.99) 3 6 71.4
  in fever 4.94 (1.00) 2 6 74.3
  in RTI 4.5 (1.04) 2 6 51.4
  in trauma 4.29 (1.32) 1 6 32.9
I Biomarkers
  in sepsis 5.09 (0.92) 3 6 74.3
  in fever 5.06 (1.06) 2 6 74.3
  in RTI 4.54 (1.20) 2 6 65.7
  in trauma 3.91 (1.40) 1 6 34.3
C, condition; I, intervention; P, process; RTI, respiratory tract infections.
Table 4 Delphi stage 3, HPP ranking of research topics in PEM 
(n=28 respondents)
hPP rank Item Mean priority (sD) Delphi rank
1 (167) Biomarkers in sepsis 5.09 (0.92) 2
2 (162) Risk stratification in sepsis 5.11 (.99) 1
3 (150) Practice variation in sepsis 5.03 (0.92) 4
4 (147) Practice variation in fever 4.66 (1.08) 6
5 (146) Biomarkers in fever 5.06 (1.06) 3
6 (144) Practice variation in RTI 4.60 (0.91) 7
7 (141) Risk stratification in fever 4.94 (1.00) 5
8 (140) Risk stratification in RTI 4.5 (1.04) 9
9 (133) Biomarkers in RTI 4.54 (1.20) 8
10 (127) Practice variation in trauma 4.37 (1.00) 10
11 (124) Risk stratification in trauma 4.29 (1.32) 11
NA Biomarkers in trauma 3.91 (1.40) 12
HPP, Hanlon prioritisation process; NA, not available; PEM, paediatric emergency 
medicine.
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(21% of countries); high-grade emergency care (meningitis/
sepsis) is provided by either secondary, tertiary care or mixed.14 
Recognising these differences is essential in developing evidence-
based management strategies and support their implementation 
across Europe.
Future of the rePeM network
Paediatrics ED presentations are responsible for a significant 
healthcare and economic burden because of non-urgent inap-
propriate visits to the ED, possible delayed diagnosis of serious 
diseases and balancing between overtesting and overtreatment 
of common benign conditions versus undertesting and under-
treatment of rare serious conditions. In the European setting, 
there is the need for homogeneous epidemiological data on 
presenting paediatric emergent conditions and practice variation 
across European EDs, to best plan sample sizes for prospective 
studies and estimate the effects of implementing novel inter-
ventions. REPEM contributes to establishment of facilities (eg, 
common data collection and management system; harmonisa-
tion and standardisation of research procedures platform) and 
promote multidisciplinary collaboration, with primary focus on 
biomarkers for fever and sepsis, or other suggested new tech-
nologies by our study (imaging and intubation in the ED). To 
provide long-term sustainability of the network and advance-
ment of research in PEM, we need investment in the capability 
of obtaining future funding for specific network research proj-
ects. This will lead to a long-lasting impact on clinical practice, 
to better patient care and a more cost-effective use of resources. 
The REPEM network has the task to contribute to knowledge 
development on best acute care practices and their implemen-
tation in routine clinical care to improve patient outcomes and 
experience of care incorporating the European diversity. In 
addition to clinical research experts in REPEM, it is essential 
to involve other key stakeholders (eg, experts on biostatistics, 
basic and translational research, effectiveness research and 
implementation science) to address the network’s challenges and 
objectives. We still need to promote inclusiveness of European 
countries' participation to PEM research to ensure a broad and 
diverse representation. Furthermore, we need to foster collabo-
ration with patients and their families, for example, to include 
patient-centred and patient-reported outcomes in future study 
projects.7 11 This will ensure that the network’s research projects 
are relevant to both paediatric emergency care end-users and 
clinicians alike.
Correction notice This article has been corrected since it first published online. 
The open access licence type has been amended. 
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